已收盘 12-12 16:00:00 美东时间
-1.250
-9.32%
Mizuho analyst Vikram Malhotra maintains Hudson Pacific Properties (NYSE:HPP) with a Neutral and lowers the price target from $21 to $15.
12-12 22:07
今日重点评级关注:B. Riley证券:维持Seabridge Gold"买入"评级,目标价从50美元升至65美元;HC Wainwright & Co.:维持TRX Gold"买入"评级,目标价从1.2美元升至1.4美元
12-03 09:58
Morgan Stanley analyst Ronald Kamdem maintains Hudson Pacific Properties (NYSE:HPP) with a Underweight and raises the price target from $2 to $14.
12-03 01:42
Hudson Pacific Properties ( ($HPP) ) has issued an announcement. On November 26...
12-02 06:29
今日重点评级关注:HC Wainwright & Co.:维持BiomX"买入"评级,目标价从15美元升至26美元;Clear Street:维持Diversified Energy"买入"评级,目标价从23美元升至25美元
11-26 10:07
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从4美元升至9美元;BTIG:维持Cullinan Therapeutics"买入"评级,目标价从32美元升至38美元
11-25 10:27
Citigroup analyst Nick Joseph maintains Hudson Pacific Properties (NYSE:HPP) with a Neutral and lowers the price target from $2.9 to $1.9.
11-25 02:45
Hudson Pacific Properties (HPP) will effect a 1-for-7 reverse stock split of its common stock, par value $0.01 per share that will become effective on December 1, 2025. HPP -1.33% after hours to $1.85...
11-18 05:32
Hudson Pacific Properties, Inc. ("Hudson Pacific" or the "Company") (NYSE:HPP) today announced that it will effect a 1-for-7 reverse stock split (the "Reverse Stock Split") of its common stock, par value $0.01 per share
11-18 05:26
今日重点评级关注:Guggenheim:维持InflaRx"买入"评级,目标价从10美元升至22美元;巴克莱:维持Tandem糖尿病护理"超配"评级,目标价从51美元升至55美元
11-11 10:49